KalVista Pharmaceuticals Inc [KALV] Investment Guide: What You Need to Know

KalVista Pharmaceuticals Inc’s recently made public that its 10% Owner Venrock Healthcare Capital Par acquired Company’s shares for reported $0.44 million on Feb 08. In the deal valued at $14.70 per share,29,747 shares were bought. As a result of this transaction, Venrock Healthcare Capital Par now holds 4,824,731 shares worth roughly $71.65 million.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Then, Venrock Healthcare Capital Par bought 51,827 shares, generating $754,601 in total proceeds. Upon buying the shares at $14.56, the 10% Owner now owns 4,794,984 shares.

Before that, Venrock Healthcare Capital Par bought 4,474 shares. KalVista Pharmaceuticals Inc shares valued at $65,947 were divested by the 10% Owner at a price of $14.74 per share. As a result of the transaction, Venrock Healthcare Capital Par now holds 4,743,157 shares, worth roughly $70.44 million.

H.C. Wainwright initiated its KalVista Pharmaceuticals Inc [KALV] rating to a Buy in a research note published on Tuesday, June 15, 2020; the price target was $30.

Price Performance Review of KALV

On Tuesday, KalVista Pharmaceuticals Inc [NASDAQ:KALV] saw its stock fall -7.42% to $14.85. Over the last five days, the stock has gained 0.13%. KalVista Pharmaceuticals Inc shares have risen nearly 21.22% since the year began. Nevertheless, the stocks have risen 86.56% over the past one year. While a 52-week high of $16.88 was reached on 02/01/24, a 52-week low of $6.26 was recorded on 01/05/24. SMA at 50 days reached $12.31, while 200 days put it at $10.26. A total of 4.46 million shares were traded, compared to the trading of 0.45 million shares in the previous session.

Levels Of Support And Resistance For KALV Stock

The 24-hour chart illustrates a support level at 13.36, which if violated will result in even more drops to 11.88. On the upside, there is a resistance level at 16.23. A further resistance level may holdings at 17.61. The Relative Strength Index (RSI) on the 14-day chart is 56.59, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.70, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.35%. Stochastics %K at 72.80% indicates the stock is a holding.

How much short interest is there in KalVista Pharmaceuticals Inc?

A steep rise in short interest was recorded in KalVista Pharmaceuticals Inc stocks on Jan 31, 2024, dropping by -1.22 million shares to a total of 2.47 million shares. Yahoo Finance data shows the prior-month short interest on Dec 29, 2023 was 3.69 million shares. There was a decline of -49.39%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 7.64% of the overall stock float, the days-to-cover ratio (short ratio) fell to 5.51.

Most Popular